HOME Research

R&D at ubio

Print
ubio excels in converting ideas into applicable technologies and affordable, accessible products. We are especially interested in mass-market biotech products, with special focus on diagnostics and healthcare.

Current research efforts at ubio are centered around development of low-cost multiplex diagnostic assays based on ubio's patent-pending low-cost biochip platform. These include work on cancer diagnostics funded by Department of Science and Industrial Research, Government of India, with focus on early cancer detection that can improve treatment efficacy manifold. ubio has entered research partnerships with leading institutions in biomedical and healthcare research, including Sree Chithra Tirunal Institute of Medical Science and Technology and Regional Cancer Centre, Trivandrum, with multiple collaborative projects in pipeline.

ubio is also actively working on developing low-cost veterinary rapid tests that can increase the use of diagnostics in animal healthcare in developing countries. These products would lower costs of animal care and farm management, and increase the accuracy and quality of treatment, driving down total costs for livestock based businesses.

ubio Biochip Platform

Print

Welcome to the home page of ubio Biotechnology Systems.

ubio is a startup biotechnology venture that focuses on biochips for clinical diagnosis. ubio has developed multiplex immuno-assays for the in-vitro diagnostic market, providing cost-effective diagnostic solutions for hospitals, laboratories and blood banks. ubio’s patent-pending biochip platform and high-performance analysis software deliver accurate test results at a cost that could be as low as half the cost of current test methods. In India, biochip market is still at nascent stage and ubio is poised to be the market leader in the biochip segment in the coming years.